Table 2

Factors Driving Growth of Pharmaceutical Expenditures in Clinics and Nonfederal Hospitals in 2016, by Product Categorya

Product CategoryClinicsNonfederal Hospitals
Total Percent GrowthPercent Growth Due to FactorTotal Percent GrowthPercent Growth Due to Factor
New ProductsPriceVolume and MixNew ProductsPriceVolume and Mix
All products11.91.91.98.13.31.64.6−3.0
 Injectables12.41.52.48.54.01.54.4−2.0
  Brands12.01.42.97.72.41.24.4−3.3
  Generics7.33.7−5.38.96.33.71.31.2
  Branded generics21.50.23.617.78.70.77.80.2
 Noninjectables10.23.50.26.51.32.05.2−5.9
  Brands12.42.82.47.20.52.09.3−10.8
  Generics1.08.5−12.44.90.63.9−2.6−0.7
  Branded generics7.50.43.23.93.00.14.8−1.8
  • a Total growth comprised growth attributable to 3 factors: (1) new products (products that were not on the market in the previous year), primarily newly approved and marketed agents, (2) price (changes in the unit cost of drugs that were on the market in the previous year), and (3) volume and mix (changes in volume of utilization of existing products or changes in utilization patterns [e.g., a shift from one product to another, as when prescribing moves from brand to generic products]).